Jenifer Mallavarpu Ambrose

Dr. Jenifer Mallavarpu Ambrose


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 March 2022 in Molecules
Verified
Journal Article
Open access
PDF file
JAJenifer Mallavarpu Ambrose
Jenifer Mallavarpu Ambrose
MKMalathi Kullappan
Malathi Kullappan
Shankargouda PatilShankargouda Patil
Shankargouda Patil
KAKhalid J. Alzahrani
Khalid J. Alzahrani
HBHamsa J. Banjer
Hamsa J. Banjer
Krishna Mohan SurapaneniKrishna Mohan Surapaneni
Krishna Mohan Surapaneni
The wild-type SARS-CoV-2 has continuously evolved into several variants with increased transmissibility and virulence. The Delta variant which was initially identified in India created a devastating impact throughout the country during the second wave. While the efficacy of the existing vaccines against the latest SARS-CoV-2 variants remains unclear, extensive research is being carried out to develop potential antiviral drugs through approaches like in silico screening and drug-repurposing. This study aimed to conduct the docking-based virtual screening of 50 potential phytochemical compounds against a Spike glycoprotein of the wild-type and the Delta SARS-CoV-2 variant. Subsequently, molecular docking was performed for the five best compounds, such as Lupeol, Betulin, Hypericin, Corilagin, and Geraniin, along with synthetic controls. From the results obtained, it was evident that Lupeol exhibited a remarkable binding affinity towards the wild-type Spike protein (−8.54 kcal/mol), while Betulin showed significant binding interactions with the mutated Spike protein (−8.83 kcal/mol), respectively. The binding energy values of the selected plant compounds were slightly higher than that of the controls. Key hydrogen bonding and hydrophobic interactions of the resulting complexes were visualized, which explained their greater binding affinity against the target proteins—the Delta S protein of SARS-CoV-2, in particular. The lower RMSD, the RMSF values of the complexes and the ligands, Rg, H-bonds, and the binding free energies of the complexes together revealed the stability of the complexes and significant binding affinities of the ligands towards the target proteins. Our study suggests that Lupeol and Betulin could be considered as potential ligands for SARS-CoV-2 spike antagonists. Further experimental validations might provide new insights for the possible antiviral therapeutic interventions of the identified lead compounds and their analogs against COVID-19 infection.

21 August 2022 in BioMed Research International
Verified
Journal Article
Open access
PDF file
MKMalathi Kullappan
Malathi Kullappan
BBBalakrishnan Anna Benedict
Balakrishnan Anna Benedict
ARAnusha Rajajagadeesan
Anusha Rajajagadeesan
PBPadmasini Baskaran
Padmasini Baskaran
NPNanthini Devi Periadurai
Nanthini Devi Periadurai
Krishna Mohan SurapaneniKrishna Mohan Surapaneni
Krishna Mohan Surapaneni
Zika virus is a member of the Flaviviridae family and genus Flavivirus, which has a phylogenetic relationship with spondweni virus. It spreads to humans through a mosquito bite. To identify potential inhibitors for the Zika virus with biosafety, we selected natural antiviral compounds isolated from plant sources and screened against NS3 helicase of the Zika virus. The enzymatic activity of the NS3 helicase is associated with the C‐terminal region and is concerned with RNA synthesis and genome replication. It serves as a crucial target for the Zika virus. We carried out molecular docking for the target NS3 helicase against the selected 25 phytochemicals using AutoDock Vina software. Among the 25 plant compounds, we identified NS3 helicase‐ellagic acid (‐9.9 kcal/mol), NS3 helicase‐hypericin (‐9.8 kcal/mol), and NS3 helicase‐pentagalloylglucose (‐9.5 kcal/mol) as the best binding affinity compounds based on their binding energies. To understand the stability of these complexes, molecular dynamic simulations were executed and the trajectory analysis exposed that the NS3 helicase‐ellagic acid complex possesses greater stability than the other two complexes such as NS3 helicase‐hypericin and NS3 helicase‐pentagalloylglucose. The ADMET property prediction of these compounds resulted in nontoxicity and noncarcinogenicity.

13 December 2021 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
AKAndiyappan Kistan
Andiyappan Kistan
BBBalakrishnan Anna Benedict
Balakrishnan Anna Benedict
SVSundaramoorthy Vasanthan
Sundaramoorthy Vasanthan
APAlphonse PremKumar
Alphonse PremKumar
MKMalathi Kullappan
Malathi Kullappan
Krishna Mohan SurapaneniKrishna Mohan Surapaneni
Krishna Mohan Surapaneni
Emergence of antibiotic-resistant Mycobacterium tuberculosis (M. tuberculosis) restricts the availability of drugs for the treatment of tuberculosis, which leads to the increased morbidity and mortality of the disease worldwide. There are many intrinsic and extrinsic factors that have been reported for the resistance mechanism. To overcome such mechanisms, chemically synthesized benzaldehyde thiosemicarbazone derivatives were screened against M. tuberculosis to find potential inhibitor for tuberculosis. Such filtering process resulted in compound 13, compound 21, and compound 20 as the best binding energy compounds against DNA gyrase B, an important protein in the replication process. The ADMET prediction has shown the oral bioavailability of the novel compounds.


30 December 2021 in Biomedical and Pharmacology Journal
Verified
Journal Article
Open access
MKMalathi Kullappan
Malathi Kullappan
JAJenifer Mallavarpu Ambrose
Jenifer Mallavarpu Ambrose
Krishna Mohan SurapaneniKrishna Mohan Surapaneni
Krishna Mohan Surapaneni
COVID-19, a pandemic disease caused by single-stranded RNA virus Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). The structural spike (S) protein of SARS-CoV-2 plays a vital role in host cell entry, where the Angiotensin-Converting Enzyme-2 (ACE2) receptor of the human cell binds to the Receptor Binding Domain (RBD) region of the S1 domain and makes cell entry. The binding affinity of SARS-CoV-2-ACE2 is tenfold higher than the SARS-CoV-1-ACE2. Recent studies expose that the SARS-CoV-2 S D614G variant is highly infectious than D614 protein, also the D614G variant is highly stable than D614. So far, there is no effective viral-specific regimen for COVID-19. To overcome such problems, in our study, we have utilized the ZINC database to screen potent leads against the highly transmitting SARS-CoV-2 spike D614G protein, through a virtual screening procedure. We have applied three computational tools iGEMDOCK server, AutoDock version 4.2.6 and admetSAR to get active leads. The ZINC000150588351 (Elbasvir), ZINC000064540179 (Sofosbuvir analogue) and ZINC000137700912 (Sofosbuvir analogue) molecules have a greater binding affinity with the high binding energies of -8.22 kcal/mol, -8.13 kcal/mol and -7.64 kcal/mol respectively. The molecules ZINC000064540179 and ZINC000137700912 have high binding energy than their core molecule Sofosbuvir (ZINC100074252) of -4.06 kcal/mol. The ADMET prediction of these molecules reveals satisfactory human intestinal absorption and non-mutagenic property. Our results deliver valuable contributions to the design of inhibitors against COVID-19.